CTOs on the Move

Contego Medical

www.contegomedical.com

 
Contego Medical, founded in 2005, has developed a family of novel emboli protection devices. The main feature of each device is that the treatment portion (i.e., balloon or stent) is on the same catheter as the embolic protection device, thus coupling the two together. This device can act as an angioplasty balloon with an integrated emboli protection device. If a stent is mounted on the balloon, it can serve as a stent with an integrated emboli protection device. We know that embolization occurs with all angioplasty and stenting procedures. It is usually hard to predict which ones will result in clinical ...
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Contego Medical raised $22M on 01/13/2020

Similar Companies

Renovia Incorporated

Renovia was formed to develop and commercialize products for better first-line diagnosis and treatment to improve the condition-specific quality of life for millions of women with pelvic floor disorders. Renovia`s technology enables treatment via precise visualization of pelvic movement in real-time during pelvic floor muscle training, while monitoring usage and progress over time. As a women`s health organization, Renovia is in pursuit of scalable and cost-effective care for pelvic floor disorders delivered through the power of digital health.

Flow Sciences Inc

Flow Sciences Inc is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

American HomePatient

Golden Helix

Golden Helix is a Bozeman, MT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NeuroOne

NeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from Epilepsy, Parkinson`s Disease, Essential Tremors and other related neurological disorders that may improve patient outcomes and reduce procedural costs.